Abbott Labs board OKs $7 billion stock buyback program
Medical device giant Abbott Laboratories is launching a $7 billion stock buyback program. The repurchase of common shares was approved by Abbott’s board of directors this month, the North Chicago-based company announced today in conjunction with revealing its third-quarter earnings.
US companies boosted their stock buyback plans this year, amidrising profits and excess cash. According to data from EPFR, ...
Microsoft recently announced a stock buyback and dividend hike. Does this news make MSFT stock a potential buy?
Alibaba (BABA) has released an update. Alibaba Group has announced changes in its share structure, having issued new shares ...
The board of Ulta Beauty has approved a $3 billion share repurchase authorization as it prepares to open 200 net new stores over the next three years. The specialty cosmetics retailer said Wednesday ...
H&R Block is a strong investment choice with share repurchases, growth potential, and a solid reputation for professional tax ...
Germany’s RWE AG management should provide clarity on whether a share buyback program will be extended at scale or rule it ...
Compass Diversified, owner of BOA, Primaloft, 5.11, and other active lifestyle brands, said its board authorized the ...
Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories is launching a $7 billion stock buyback program. The North Chicago-based company made the ...
Global stocks rise as China's central bank unveils a plan to boost share buybacks, lifting markets in Europe and Asia. The move aims to stabilize China's economy amid ongoing property market ...
China’s central bank has kicked off a specialized re-lending facility for listed companies and major shareholders to buy back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback